The 6th World Congress on Breast Cancer is an internationally acclaimed scientific gathering scheduled to take place on July 27-28, 2026, in Rome, Italy. This two-day congress brings together clinicians, researchers, oncologists, surgeons, pathologists, radiologists, pharmaceutical representatives, policy makers, patient advocates, and students from around the world. The event focuses on innovation, education, and collaboration, providing a significant platform to explore recent advancements, breakthroughs, and challenges in breast cancer research, diagnosis, treatment, and patient care. The conference is designed to cover basic and translational research, clinical trials, surgical and radiation oncology, immunotherapy, targeted therapy, genetics and genomics, liquid biopsies, AI and digital imaging, molecular biology, nursing and patient-centered care, and survivorship issues. Special sessions will be dedicated to HER2-positive and triple-negative breast cancer, metastatic disease, male breast cancer, young women with breast cancer, and breast cancer in low- and middle-income countries. The congress will feature scientific sessions and keynote addresses delivered by world-renowned experts, providing a unique blend of historical richness, cultural diversity, and scientific excellence. The selection of Rome as the host city offers a perfect blend of intellectual exploration, cultural heritage, and modern infrastructure. Delegates will have the opportunity to experience a scientifically rewarding program while enjoying the charm of the Eternal City. The conference will cover topics such as immunotherapy in breast cancer, breast cancer survivorship and quality of life, triple-negative breast cancer research, and more. The event aims to unite experts and provide a platform for collaboration and knowledge sharing, with the ultimate goal of transforming breast cancer care.